Endothelin antagonists
US7365093B2 · kind B2 · utility
11Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2005 |
| Grant date | Apr 29, 2008 |
| Priority date | — |
| Expiry date | Dec 9, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of the formula (I):or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.